POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).
Clinical trial NCT00700401 · COMPLETED
Trial details
- NCT number
- NCT00700401
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-11-01
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.